Dowling & Yahnke LLC Moderna, Inc. Transaction History

Dowling & Yahnke LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$126.46 - $235.05 $114,319 - $212,485	-904 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $11,291 - $18,425	-50 Reduced 5.24%	904 $230,000
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $123,934 - $224,170	954 New	954 $224,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

Stay updated on Dowling & Yahnke LLC with notifications on news.